Table 3.

Overall Clinical Outcome for the SCOUT-CAP^a Trial (From Most to Least Desirable)

Survival; adequate clinical response; no adverse events Survival; adequate clinical response; mild adverse event(s) Survival; adequate clinical response; moderate adverse event(s) Survival; adequate clinical response; severe adverse event(s) Survival; inadequate clinical response without additional emergency department or clinic visit or hospitalization Survival; inadequate clinical response with additional emergency department or clinic visit but without hospitalization; any grade of adverse event Survival; inadequate clinical response with hospitalization; any grade of adverse event Death

Adequate clinical response was defined based on absence of all of the following as assessed on day 11–14 after initiation of therapy: (1) fever unless related to a new process that is unrelated to the prior diagnosis of pneumonia, (2) tachypnea, (3) increased work of breathing (retractions, nasal flaring, grunting), and (4) a medically attended visit to an emergency department/clinic or hospitalization for persistent or worsening pneumonia at any time after randomization. This is a draft version from a developing clinical trial.

^a Short-Course Outpatient Therapy for Community-Acquired Pneumonia in Children.